KANEKO YASUNORI 4
4 · Arcus Biosciences, Inc. · Filed Apr 26, 2021
Insider Transaction Report
Form 4
KANEKO YASUNORI
Director
Transactions
- Purchase
Common Stock
2021-04-23$31.37/sh+4,133$129,652→ 7,133 total
Holdings
- 131,948(indirect: By Trust)
Common Stock
- 505,050(indirect: By LLC)
Common Stock
- 252,524(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]Shares purchased in a private transaction from Dr. William Grossman, Arcus's Chief Medical Officer.
- [F2]Thirty-five thousand (35,000) shares previously held directly by the reporting person were transferred to reporting person's trust.
- [F3]The reporting person's direct ownership includes three thousand (3,000) shares that are Restricted Stock Units that will not vest until June 3, 2021.